Brief: MannKind Completes Acquisition Of ScPharmaceuticals, Accelerating Revenue Growth In Cardiometabolic Care
07/10/2025 14:10
Oct 7 (Reuters) - MannKind Corp MNKD.O: MANNKIND COMPLETES ACQUISITION OF SCPHARMACEUTICALS, ACCELERATING REVENUE GROWTH IN CARDIOMETABOLIC CARE Source text: ID:nGNX5Rp9Vb Further company coverage: MNKD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MannKind
See all newsBrief: MannKind Enters Data-Rich Development Period With Completion Of Randomization In Phase 1B Inflo-1 Study And Enrollment Of First Patient In Phase 2 Inflo-2 Trial For Nintedanib Dpi In Patients With Ipf
U.S. STOCKS ON THE MOVE-Dell, Gap, Costco
MannKind rises after FDA approves inhaled insulin for children
US FDA approves MannKind's inhaled insulin for children (updated)
US FDA approves MannKind's inhaled insulin for children